Adverum Biotechnologies, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 29.06 million compared to USD 37.91 million a year ago. Basic loss per share from continuing operations was USD 2.9 compared to USD 3.8 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | -2.94% | -5.47% | +0.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 158M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023